CHU Nimes, Instiut de Cancerologie du Gard, Medical Oncology

Nîmes 30029

0 studies enrolling now · 1 studies all time

What they study most

Locally Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck

Studies at this site

• Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN — Withdrawn before enrolling